Your molecule


A continuum of capabilities

A support at every stage of the product lifecycle

With 25 years of experience in process development, scale-up and ongoing cGMP manufacturing of small molecule APIs, we support emerging, specialty and large pharmaceutical customers for their drug substance or drug delivery needs.


Highly efficient manufacturing capabilities

As a fully integrated CDMO, Seqens is uniquely positioned to address the continuum of the API value chain : API, HPAPI, cGMP & non-GMP intermediates, RSM, controlled substances, excipient for drug delivery


A trusted supplier
of proprietary APIs

More than 50 APIs have been successfully launched in the United States, Europe and Japan with consistently superior quality, reliability and customer service, supported by regulatory documentation to meet the most stringent standards from local agencies


A continuum of technologies

8 industrial plants and 3 R&D centers in Europe, North America and Asia.

More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.




Seqens Named Best Pharmaceutical Synthesis Company 2019

Best Pharmaceutical Synthesis Company 2019 It is both gratifying and humbling to be notified that you have won awards, particularly those you…

How Compatible Do a CDMO and Sponsor Need to Be?

There is no Match, eHarmony, Bumble or other dating site where sponsors can meet their ideal Contract Development and Manufacturing Organization (CDMO)…
API Manufacturing

10 Factors to Consider When Picking a Partner for Commercial Scale API Manufacturing

Congratulations! Clinical trials have proven successful and now on to the next major decision as you prepare for product launch: finding the right…

Seqens CDMO global presence

Use interactive map

6 cGMP/FDA inspected sites in EU & US


Pre-GMP sites for RSMs & Intermediates


M3 capacity


DMFs for commercial APIs


Scientists, experts and engineers


R&D centers in UE and US